Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI
JACC: Cardiovascular Interventions · 2024
DOI: 10.1016/j.jcin.2024.04.038 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Claudio Laudani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "Rodolico-San Marco," University of Catania, Catania, Italy. Hauptthemen laut MEDLINE: Ticagrelor, Clopidogrel, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "Rodolico-San Marco," University of Catania, Catania, Italy.
- Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA. Electronic address: dominick.angiolillo@jax.ufl.edu.
Zitieren
APA
Laudani, C., & Angiolillo, D. J. (2024). Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.04.038
Vancouver
Laudani C, Angiolillo DJ. Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI. JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2024.04.038
BibTeX
@article{Laudani2024,
author = {Laudani, Claudio and Angiolillo, Dominick J},
title = {Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
doi = {10.1016/j.jcin.2024.04.038}
}
EUVIMED